Legal & General Group PLC (LON:LGEN)

Investment Thesis

👁 What to Watch

• H1 2026 results (est. August 2026) — EPS trajectory, Solvency II update, interim dividend, BPA volumes
• Solvency II coverage ratio staying within 160–190% operating range
• £600m buyback Tranche 1 completing on schedule (by 18 September 2026)
• BPA volumes tracking toward the £50bn UK market opportunity for 2026
• LGIM net flows stabilising or turning positive
• Private markets AUM progress toward £85bn target by 2028
• Fee-based profit mix moving toward 70–75% of total group profit

Stripping away the accounting noise, the financial health picture at Legal & General is materially stronger than traditional metrics suggest. The Health score of 74 under the insurer-profile methodology captures the structural features of an insurance balance sheet: Solvency II capital surplus generation, the quality of the liability-matched investment book, and the group's ability to service its obligations and grow distributions simultaneously.

The most significant balance-sheet development in FY2025 was the sharp reduction in long-term debt from £7.4 billion to £4.6 billion — a direct consequence of the $2.3 billion Meiji Yasuda disposal of the US protection arm. This is real balance-sheet simplification, reflected in the F-Score of 7/9 (Strong Improver) and the passing of all four profitability sub-tests: positive ROA, improved operating cash flow, rising earnings quality, and an OCF/net income ratio of 9.1x that confirms earnings are very well backed by actual cash generation. The F-Score was also boosted by improved liquidity (current ratio rising from 22.4x to 59.1x year-on-year) and reduced debt. One sub-test was not passed: share dilution (share count slightly higher as the buyback programme ramps — this is expected to reverse as the £1.2bn programme progresses).

The Solvency II framework is the correct lens for capital health. The pro-forma ratio of 210% — after accounting for the Meiji Yasuda proceeds, the final dividend, and the £1.2 billion buyback commitment — comfortably exceeds both the regulatory minimum and LGEN's new self-imposed operating range of 160–190%. Management's decision to set a lower operating range than historically maintained signals confidence that surplus generation is sufficient to sustain capital returns even with less headroom. The Dividend Health score of 71 is the most informative Spriggl sub-score for this company: nine years of unbroken dividend growth, a 4.1% five-year CAGR, and sustainability underpinned by Solvency II surplus generation.

The Spriggl Quality score of 47 for Legal & General reflects the ongoing challenge of applying profitability metrics — net margin, ROE, ROA — to an insurance business operating under IFRS 17, where reported net income swings between £0.2 billion and £2.1 billion from year to year based on liability revaluation movements that have nothing to do with underlying business performance. The reported operating margin of 6.6% and net margin of 4.0% are accounting-influenced figures; the ROE of 21.8% is more informative but still affected by volatility in the equity base. The Trend score of 78 (Strong) is the more useful signal: it captures momentum, and the momentum here is positive.

Core operating profit is the correct profitability anchor for LGEN. The FY2025 outcome of £1.62 billion (+6% on FY2024's £1.53 billion, itself up from £1.46 billion in FY2023 and £1.16 billion in FY2022) represents a consistent multi-year compounding trajectory. Core operating EPS of 20.93p grew 9% in FY2025 — ahead of the 6–9% target range — partly due to the benefit of the ongoing buyback reducing the denominator. Management has guided 2026 core EPS growth to come in at the top of the same 6–9% range. If delivered, that implies core EPS of approximately 22.2–22.8p for FY2026.

The quality of earnings is improving structurally as well as cyclically. The strategic shift toward fee-based profit — combining LGIM's capital-light management fees with growing private markets income — is designed to reduce the group's dependence on spread income from its insurance book, which is inherently more volatile and capital-intensive. The target of 70–75% fee-based profit mix by 2028 would materially improve earnings quality and could support a higher forward multiple. Free cash flow margin of 35.9% on a cash-flow basis confirms substantial real cash generation, with Price/FCF of 3.5x.

The Spriggl Growth score of 33 reflects the algorithmic model's response to IFRS 17 distortions in reported revenue and earnings: the data shows net income contracting 60.4% over a decade and revenue growth decelerating, neither of which reflects the true operational trajectory. The meaningful growth signals are the 6–9% annual core operating EPS trajectory, the structural tailwind from the UK pension de-risking market, and the private markets AUM build. The UK bulk purchase annuity market is forecast to reach £50 billion in 2026 alone — LGEN expects more than ten transactions exceeding £1 billion to complete this year.

LGIM's growth profile is more nuanced. The division manages £1.59 trillion of assets and generates capital-light fee income, but has faced net outflows in recent years as passive mandates and index funds commoditise part of the traditional institutional AM value proposition. The strategic response — targeting £85 billion of private markets AUM by 2028 (from £71 billion in Q3 2025) — is designed to shift the mix toward higher-margin, less commoditisable alternative strategies. The Blackstone partnership is expected to enhance private credit and real assets capabilities.

The Retail division provides the steadiest underlying growth. DC workplace pensions are a volume-driven structural growth story as auto-enrolment continues to funnel new savers into the accumulation phase. Retail annuities recovered strongly in FY2025 (£1.8 billion of volumes) as higher interest rates made annuity pricing attractive again for retiring savers. The combined effect of these three divisions creates a diversified growth profile: Institutional Retirement grows with the BPA market, Asset Management grows with private markets penetration, and Retail grows with UK savings habits and demographic tailwinds.

The Spriggl Value score of 39 reflects genuine ambiguity rather than a clear verdict. For LGEN the standard valuation toolkit needs significant adaptation. The trailing P/E of approximately 35.6x is an artefact of IFRS 17 distorting reported net income; the only useful earnings multiple is the forward P/E of approximately 11x on core operating EPS. At that multiple, LGEN is priced as a steady, modest-growth income stock with little expectation of re-rating — a reasonable description of market sentiment but one that arguably misses the combination of buyback-enhanced EPS growth, structural BPA market tailwinds, and the optionality in the private markets asset management build-out. The Price/FCF of 3.5x confirms the stock looks attractive on a cash-flow basis.

Total shareholder yield is the most compelling valuation argument for the income case. The 7.73% dividend yield (22p annualised DPS) alone substantially exceeds the 10-year gilt yield. Add the buyback yield of approximately 7.8% (£1.2 billion buyback on a £15.6 billion market cap), and total cash return to shareholders in FY2026 is running at close to 15–16% of market cap — an unusual degree of capital return for a FTSE 100 financial. Even applying a significant discount for Solvency II sensitivity risk, the income proposition is exceptional by UK large-cap standards.

The price scenario analysis provides a useful frame. A base case of 265–285p assumes about 11x forward core earnings and modest dividend growth — essentially the stock drifting sideways with income carrying total returns. The bull case of 320–340p requires both sustained top-end EPS growth and a multiple re-rating to 13–14x as the market recognises LGEN's capital return commitment and the quality of its earnings franchise. The bear case of 200–220p reflects Solvency II stress: a credit event or sustained market dislocation that forces the group to preserve capital at the expense of buybacks or dividend growth.

Legal & General's dividend record is one of the strongest in the FTSE 100. Nine consecutive years of dividend growth — maintained through COVID, the post-Truss gilt crisis, and the IFRS 17 transition — reflects an explicit management commitment to progressive dividends backed by the group's Solvency II surplus generation rather than by reported IFRS earnings, which fluctuate considerably. The full-year FY2025 dividend of 21.79p (interim 6.12p + final 15.67p) represents a 2% increase on FY2024's 21.63p. The five-year CAGR is 4.1% and the dividend has grown steadily from 17.57p in 2020 to 21.79p today. The FY2025 final dividend of 15.67p per share was paid on 4 June 2026, with directors reinvesting under the Dividend Reinvestment Plan — a positive alignment signal.

The 2% FY2025 increase was at the lower end of recent growth rates, reflecting deliberate capital allocation: the group chose to direct a larger proportion of surplus to the record £1.2 billion buyback rather than accelerating dividend growth in a single year. Management has committed to the dividend growth policy through FY2027 as part of the £5 billion+ shareholder returns programme. At 7.73% yield, the dividend is not just a competitive income proposition — it is the primary reason most FTSE 100 income funds hold the stock, and any threat to it would cause a material share price reaction.

Sustainability is underpinned by the Solvency II framework, not IFRS. The Dividend Health score of 71 correctly identifies this as a strong-quality dividend. The primary dividend risk is a Solvency II stress event (credit spread widening, adverse interest rate movement) that forces the board to prioritise capital preservation over distributions — a tail risk, not a base case, but one that the reduced buffer under the new 160–190% operating range makes marginally more likely than before. The DPS trajectory in the Spriggl data shows: 2021: 17.82p, 2022: 19.37p, 2023: 20.77p, 2024: 21.63p, 2025: 21.79p.